Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. PATH
2. AZO
3. KBH
4. ONON
5. PRGS
6. ORCL
7. RCL
8. PLTR
9. SPY
10. ACN

Go back to Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2019 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Misses Q4 EPS by 15c, Revenues Miss

March 25, 2020 4:12 PM EDT

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.72), $0.15 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $416 thousand versus the consensus estimate of $590 thousand.

"We are energized by our progress in hemp, wheat and soy in 2019 and the strength with which we enter 2020 to grow our GoodHempTM seed sales, Hawaiian CBD oils, and GoodWheatTM flour and grain sales," said Matthew Plavan, president and CEO. "Moreover, as we take stock... More